The Self-Driving Laboratory for Human Organ Mimicry is one of six self-driving labs launched by the Acceleration Consortium to drive research across a range of fields.
The University of Toronto is home to a new “self-driving lab” that will allow researchers to understand better health and disease and more rapidly test the efficacy and toxicity of new drugs and materials.
The Self-Driving Lab for Human Organ Mimicry will use organoids and organs-on-chips – a well plate pictured here – to allow researchers to move potential therapeutics to human clinical trials rapidly. Illustration by Rick Lu / University of Toronto
Based at the Donnelly Centre for Cellular and Biomolecular Research, the Self-Driving Laboratory for Human Organ Mimicry is the latest self-driving lab to spring from a historic $200-million grant from the Canada First Research Excellence Fund to the Acceleration Consortium – a global effort to speed the discovery of materials and molecules that is one of several U of T institutional strategic initiatives.
The new lab will be led by Milica Radisic, Canada Research Chair in Organ-on-a-Chip Engineering and professor of biomedical engineering in the Faculty of Applied Science & Engineering, and Vuk Stambolic, senior scientist at the Princess Margaret Cancer Centre, University Health Network, and professor of medical biophysics in the Temerty Faculty of Medicine.
“The lab will innovate new complex cellular models of human tissues, such as from the heart, liver, kidney and brain, through stem-cell-derived organoids and organ-on-a-chip technologies,” said Radisic.
“In partnership with the Princess Margaret Cancer Centre, the lab will also enable automation of patient-derived tumor organoid cultures to accelerate the discovery of new cancer treatments.”
Tumour organoids stained with fluorescent dyes. Image credit: Nikolina Radulovich and Laura Tamblyn / University of Toronto
The Self-Driving Laboratory for Human Organ Mimicry is one of six self-driving labs launched by the Acceleration Consortium at U of T to drive research across various fields, including materials, drug formulation, drug discovery and sustainable energy.
How does a self-driving lab work? Once set up, it runs with robots and artificial intelligence performing as much as 90 per cent of the work. That, in turn, speeds up the discovery process by freeing researchers from the tedious process of trial and error so they can focus on higher-level analysis.
“The Self-Driving Lab for Human Organ Mimicry will enable other self-driving labs to develop new materials and drugs by rapidly determining their efficacy, as well as their potential toxic effects and other impacts on human tissues,” said Stambolic.
“While animal testing is typically the go-to method to assess the safety of new molecules made for humans, this lab will replace trials involving animals with organoids and organs-on-chips. This will allow us to advance to human clinical trials much more quickly.”
Professors Milica Radisic and Vuk Stambolic. Image credit: University of Toronto
“The goal of our self-driving labs is to use AI to move the discovery process forward at the necessary pace to tackle global issues,” said Alán Aspuru-Guzik, director of the Acceleration Consortium and professor of chemistry and computer science in the Faculty of Arts & Science.
“The Human Organ Mimicry SDL, as well as other self-driving labs launched through the Acceleration Consortium, will establish U of T and our extended research community as a global leader in AI for science.”
Donnelly Centre Director Stephane Angers says the centre is an ideal environment for the new lab, citing the international hub for cross-disciplinary health and medical research’s reputation as a hotspot for technological innovation – one that offers resources to the wider research community.
“The Donnelly Centre is a thriving research community because it was founded on the principle of interdisciplinary collaboration,” said Angers, a professor of biochemistry and pharmaceutical sciences. “Our research strengths in computational biology, functional genomics and stem cell biology will catalyze the development and success of the Self-Driving Lab for Human Organ Mimicry.”
The launch of the new lab will also expand the Donnelly Centre’s team of experts by hiring five new staff to make the self-driving lab fully automated. The lab is expected to be operational by the end of the year
“The Donnelly Centre is one of the foremost research institutes in the world, with outstanding strength in genomics, model organisms, organoids, computational biology and many other areas,” said Justin Nodwell, vice-dean of research and health science education at the Temerty Faculty of Medicine.
“I’m delighted to hear about the addition of the Acceleration Consortium’s artificial intelligence-powered self-driving lab to the centre’s existing technical base. It will facilitate new lines of research by some of the best minds in the country.”
Source: University of Toronto